Formulations of N- (2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl5-isoxazolyl)amino]sulfonyl}-2-thiophen ecarboxamide

Details for Australian Patent Application No. 2008269149 (hide)

Owner Encysive Pharmaceuticals, Inc.

Inventors Rajewski, Lian; Amsberry, Kent; Trammel, Andrew; Schoeneman, Aaron; Chen, Jinling

Agent Spruson & Ferguson

Pub. Number AU-A-2008269149

PCT Pub. Number WO2009/002490

Priority 60/937,215 25.06.07 US

Filing date 24 June 2008

Wipo publication date 31 December 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2009/002490 Priority application(s): WO2009/002490

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008269151-Image guided plaque ablation

2008269148-Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin